RCUS – arcus biosciences, inc. (US:NASDAQ)
Stock Stats
News
6/25
04:35 pm
rcus
Medium
Arcus Biosciences Announces New Employment Inducement Grants
6/24
10:05 am
rcus
Low
Arcus Biosciences, Inc. (NYSE: RCUS) had its price target lowered by analysts at Truist Financial Co. from $50.00 to $44.00. They now have a "buy" rating on the stock.
6/11
04:35 pm
rcus
Low
Arcus Biosciences Announces New Employment Inducement Grants
6/10
08:49 am
rcus
Medium
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers [Yahoo! Finance]
6/10
08:30 am
rcus
Medium
Arcus Biosciences Completes Patient Enrollment in Phase 3 Trial Evaluating a Domvanalimab-Containing Regimen in First-Line Metastatic Upper GI Cancers
5/8/2024
04:02 pm
RCUS
5.8%
BEAT
2/21/2024
04:05 pm
RCUS
19.9%
BEAT
11/7/2023
04:00 pm
RCUS
-2.7%
BEAT
8/7/2023
08:00 am
RCUS
-4.3%
MISS
6/3
11:09 am
Maintains
Buy
Buy
Citigroup
Medium
-6.3%
6/3
11:09 am
Maintains
Buy
Buy
Citigroup
Medium
-6.3%
5/9
09:06 am
Reiterates
Outperform
Outperform
Wedbush
Low
0.9%
5/9
09:06 am
Reiterates
Outperform
Outperform
Wedbush
Low
0.9%
5/9
08:49 am
Reiterates
Outperform
Outperform
Wedbush
Low
0.9%
6/18
04:55 pm
rcus
Low
Form 4 Arcus Biosciences, Inc. For: Jun 15 Filed by: ROSEN TERRY J
6/18
04:54 pm
rcus
Low
Form 4 Arcus Biosciences, Inc. For: Jun 15 Filed by: Tang Carolyn C.
6/18
04:54 pm
rcus
Low
Form 4 Arcus Biosciences, Inc. For: Jun 15 Filed by: Jaen Juan C.
6/18
04:54 pm
rcus
Low
Form 4 Arcus Biosciences, Inc. For: Jun 15 Filed by: Jarrett Jennifer
6/7
06:21 pm
rcus
Medium
Form 4 Arcus Biosciences, Inc. For: Jun 06 Filed by: KANEKO YASUNORI
Show more
Top News Gainers
9/26 Arcus Biosciences Inc (NYSE: RCUS) is now covered by analysts at Mizuho. They set a "buy" rating on the stock. 15.6%
2/18 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $13.00 price target on the stock. 12.7%
8/8 Arcus Biosciences Inc (NYSE: RCUS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 11.0%
3/4 Arcus Biosciences Inc (NYSE: RCUS) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $24.00 price target on the stock. 7.7%
6/11 Arcus Biosciences to Provide a Mid-Year Update on Clinical and Preclinical Programs 6.4%
11/12 Arcus Biosciences Inc (NYSE: RCUS) is now covered by analysts at SunTrust Banks, Inc.. They set a "buy" rating on the stock. 5.4%
4/9 Arcus Biosciences Announces New Employment Inducement Grants 5.3%
12/18 Arcus Biosciences, in Collaboration with Genentech, Announces Two Randomized Clinical Studies to Advance AB928, a Dual Adenosine Receptor Antagonist, into Novel Combinations for Colorectal and Pancreatic Cancers 4.9%
10/30 Form 4 Arcus Biosciences, Inc. For: Oct 28 Filed by: Ribas Antoni 4.5%
7/4 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock. 4.4%
Top News Decliners
3/14 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -24.3%
2/25 Arcus Biosciences Inc (NYSE: RCUS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -9.5%
11/25 Form 8-K/A Arcus Biosciences, Inc. For: Sep 10 -8.8%
4/7 Form 8-K Arcus Biosciences, Inc. For: Apr 07 -7.6%
11/7 Arcus Biosciences Inc (NYSE: RCUS) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -7.3%
10/4 Form 3 Arcus Biosciences, Inc. For: Oct 01 Filed by: Barker Jason -6.7%
4/16 Arcus stock jumps on Bloomberg News report that Gilead may take a stake [MarketWatch] -6.3%
3/3 Arcus Biosciences Inc (NYSE: RCUS) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $17.00 price target on the stock. -5.3%
2/22 3 Biotech Stocks That Soared This Week: Are They Buys? [The Motley Fool] -5.1%
2/26 Arcus Biosciences Inc (NYSE: RCUS) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $22.00 price target on the stock. -4.8%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3